# Cancer Loyalty Card Study 2 (CLOCS-2)

> **NCT06447064** · — · RECRUITING · sponsor: **Imperial College London** · enrollment: 2900 (estimated)

## Conditions studied

- Pancreatic Cancer
- Colon Cancer
- Oesophageal Cancer
- Stomach Cancer
- Liver Cancer
- Bladder Cancer
- Uterine Cancer
- Vulvar Cancer
- Ovarian Cancer
- Endometrial Cancer

## Interventions

- **OTHER:** Cases & Controls

## Key facts

- **NCT ID:** NCT06447064
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-04
- **Primary completion:** 2027-02
- **Final completion:** 2027-04
- **Target enrollment:** 2900 (ESTIMATED)
- **Last updated:** 2026-03-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06447064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06447064, "Cancer Loyalty Card Study 2 (CLOCS-2)". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06447064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*